NCT03503149

Molecular Tumor Board at the Center for Personalized Medicine Tübingen

Molecular Tumor Board at the Center for Personalized Medicine Tübingen: a Prospective Observational Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (estimated)
• Sponsor: University Hospital Tuebingen · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: —

Summary

Molecular Tumor Board at the Center for Personalized Medicine

Detailed description

Molecular Tumor Board at the Center for Personalized Medicine The study objectives are * To ensure a prospective documentation of all patients who are referred to the Molecular Tumor Board in routine clinical care * To prospectively ensure the documentation of MTB patients with an emphasis to clinical outcome parameters progression-free survival (PFS), overall survival (OS) and further response assessments (e.g. peripheral immunmonitoring, imaging parameters) * To prospectively assess patient-reported outcome of MTB patients * To evaluate compliance to MTB suggestions in routine clinical care

Conditions

• Advanced Cancer

Interventions

Type	Name	Description
OTHER	no intervention	observational study

Timeline

• Start date: 2018-03-01
• Primary completion: 2028-03-01
• Completion: 2028-03-01
• First posted: 2018-04-19
• Last updated: 2018-04-19

Locations

1 site across 1 country: Germany